Table 3.
Cancer type | |||
---|---|---|---|
| |||
Breast cancer AOR (95%CI) | Colorectal cancer AOR (95%CI) | Prostate cancer AOR (95%CI) | |
MetS diagnosis | |||
No | Ref | Ref | Ref |
Yes | 1.20(1.03–1.39) | 0.93(0.88–0.99) | 1.22(1.09–1.37) |
Age groups | |||
≧ 40 < 50 | Ref | Ref | Ref |
≧ 50 < 60 | 1.07(0.97–1.19) | 1.01(0.95–1.07) | 1.10(0.94–1.28) |
≧ 60 < 70 | 0.97(0.87–1.09) | 1.03(0.97–1.09) | 1.13(0.97–1.31) |
≧ 70 | 0.92(0.80–1.06) | 0.99(0.93–1.05) | 0.77(0.65–0.91) |
Gender | |||
Males | - | Ref | - |
Females | - | 0.75(0.73–0.77) | - |
Race | |||
Whites | Ref | Ref | Ref |
Blacks | 0.94(0.84–1.06) | 0.86(0.82–0.90) | 1.05(0.96–1.14) |
Hispanics | 0.93(0.81–1.07) | 0.89(0.84–0.94) | 1.01(0.89–1.14) |
Others | 0.88(0.75–1.03) | 0.94(0.89–1.00) | 1.06(0.94–1.21) |
Region | |||
Large metro | Ref | Ref | Ref |
Small metro | 1.05(0.97–1.15) | 1.04(1.00–1.07) | 1.14(1.06–1.22) |
Micropolitan | 1.11(0.97–1.27) | 1.12(1.07–1.18) | 1.17(1.05–1.30) |
Not metro or micro | 1.09(0.93–1.28) | 1.03(0.97–1.08) | 1.11(0.98–1.26) |
Area-level income | |||
Q4-highest | Ref | Ref | Ref |
Q3 | 1.00(0.91–1.10) | 1.03(0.99–1.07) | 0.98(0.90–1.06) |
Q2 | 1.00(0.90–1.11) | 0.99(0.95–1.03) | 1.03(0.95–1.12) |
Q1-lowest | 0.92(0.82–1.03) | 0.90(0.86–0.94) | 0.96(0.88–1.06) |
Insurance | |||
Private | Ref | Ref | Ref |
Medicaid | 0.89(0.78–1.01) | 0.76(0.71–0.81) | 0.73(0.61–0.89) |
Medicare | 0.98(0.88–1.09) | 0.97(0.93–1.01) | 0.98(0.91–1.06) |
Other | 0.89(0.78–1.01) | 0.79(0.74–0.84) | 0.91(0.79–1.05) |
# Comorbiditiesa | 1.10(1.03–1.17) | 0.90(0.88–0.92) | 0.96(0.90–1.01) |
Metastasis | |||
Non-metastatic/in situ | Ref | Ref | Ref |
Metastatic | 0.68(0.63–0.74) | 0.87(0.84–0.89) | 0.30(0.24–0.56) |
Cancer surgery* | |||
No | Ref | Ref | - |
Yes | 0.83(0.77–0.90) | 2.28(2.22–2.35) | - |
Discharge disposition | |||
Routine discharge | Ref | Ref | Ref |
Skilled nursing facility | 1.34(1.23–1.47) | 1.45(1.41–1.50) | 1.03(0.93–1.14) |
Expired | 0.57(0.40–0.80) | 1.30(1.19–1.41) | 0.37(0.24–0.56) |
Other | 1.07(0.97–1.17) | 1.41(1.36–1.46) | 1.09(1.01–1.18) |
Length of stay | 1.08(1.07–1.09) | 1.11(1.11–1.11) | 1.26(1.25–1.27) |
Comorbidities assessed based on ICD9 codes for the following: myocardial infarction, chronic heart failure, peripheral vascular disease, cerebrovascular disease, dementia, cardio-pulmonary disease, rheumatic disease, peptic ulcer disease, mild liver disease, hemiplegia, paraplegia, renal disease, liver disease, and HIV/AIDS
Cancer-specific surgeries